• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® HIV-1/HIV-2 QUALITATIVE (192T); LAB-BASED HIV NAT DIAGNOSTIC AND/OR SUPPLEMENTAL TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® HIV-1/HIV-2 QUALITATIVE (192T); LAB-BASED HIV NAT DIAGNOSTIC AND/OR SUPPLEMENTAL TEST Back to Search Results
Catalog Number 09040528190
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/31/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The cobas 5800 serial number was (b)(6).The investigation indicated no product-related issues were identified.The root cause is due to differences in technology.Confirmatory testing detects antibiodies against hiv-1 and hiv-2, as well as some viral antigens.Because it relies on the body's immune response, it takes longer to become positive, typically 3 to 8 weeks (or sometimes longer) after exposure.
 
Event or Problem Description
There was an allegation of discrepant cobas® hiv-1/hiv-2 qualitative (192t) results from the cobas 5800 analyzer for a single patient.On (b)(6) 2026, the initial sample was generated hiv-1 reactive (38.9), hiv-2 non-reactive results.Repeat on (b)(6) 2026 generated hiv-1 reactive (38.21), hiv-2 non-reactive results.The elecsys hiv combi generated a positive result (3,63 - 3,68 ¿ 3,73 s/co).The bio-rad geenius hiv 1/2 supplemental assay generated a negative result.Serology was negative.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS® HIV-1/HIV-2 QUALITATIVE (192T)
Common Device Name
LAB-BASED HIV NAT DIAGNOSTIC AND/OR SUPPLEMENTAL TEST
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer (Section G)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
9253534412
MDR Report Key25373029
Report Number2243471-2026-02175
Device Sequence Number21129132
Product Code QST
UDI-Device Identifier00875197006384
UDI-Public00875197006384
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
BP190360/10
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 06/03/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2026
Device Catalogue Number09040528190
Device Lot NumberM25538
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/06/2026
Initial Report FDA Received Date06/03/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-